Aesica Appoints Chris Gowland as Chief Operating Officer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Aesica Appoints Chris Gowland as Chief Operating Officer


Aesica, a global contract development and manufacturing organization (CDMO), announced that it has appointed Chris Gowland as Chief Operating Officer. This new position was created to further enhance the company’s operational performance in APIs and formulated product manufacturing services.

As COO, Gowland has overall responsibility for all operating strategy, which includes setting of operational standards and driving continuous improvement across the company’s manufacturing capabilities in API and formulated products.

He will also be responsible for the management of capital expenditure, procurement of materials and services, managing the supply chain, and overseeing capacity expansion across the group to ensure that Aesica meets full customer demand whilst delivering maximum service value.

Gowland is now in charge of the operational performance and general management of all Aesica manufacturing sites including Queenborough and Cramlington in the UK, Monheim and Zwickau in Germany, and Pianezza in Italy.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here